New approaches to the treatment of giardiasis

Current Opinion in Infectious Diseases

Volumn 24, Issue 5, 2011, Pages 451-456

  Tejman Yarden, Noa ^a   Eckmann, Lars ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

antimicrobials; diarrheal disease; drug resistance; giardiasis; protozoan parasites

Indexed keywords

4 NITROIMIDAZOLE; ALBENDAZOLE; ANTISPOROZOAL AGENT; ARGININE DEIMINASE; BENZIMIDAZOLE DERIVATIVE; CHLOROQUINE; DAIDZEIN; FORMONONETIN; FURAZOLIDONE; MEBENDAZOLE; MEPACRINE; METRONIDAZOLE; NITAZOXANIDE; NITROFURAN; ORNIDAZOLE; PAROMOMYCIN; SECNIDAZOLE; TINIDAZOLE;

DRUG POTENCY; GIARDIA; GIARDIASIS; HIGH THROUGHPUT SCREENING; HUMAN; NONHUMAN; PREVALENCE; REVIEW; TRICHOMONAS VAGINALIS; UNSPECIFIED SIDE EFFECT;

ANTIPROTOZOAL AGENTS; GIARDIASIS; HUMANS;

EID: 80052481289     PISSN: 09517375     EISSN: 14736527     Source Type: Journal    
DOI: 10.1097/QCO.0b013e32834ad401     Document Type: Review

References (37)

1. Wensaas KA, Langeland N, Rortveit G. Postinfectious gastrointestinal symptoms after acute giardiasis. A 1-year follow-up in general practice. Fam Pract 2010; 27:255-259.
2. Escobedo AA, Cimerman S. Giardiasis: a pharmacotherapy review. Expert Opin Pharmacother 2007; 8:1885-1902. (Pubitemid 47321523)
3. Nash TE, Ohl CA, Thomas E, et al. Treatment of patients with refractory giardiasis. Clin Infect Dis 2001; 33:22-28. (Pubitemid 32554498)
4. Lemee V, Zaharia I, Nevez G, et al. Metronidazole and albendazole susceptibility of 11 clinical isolates of Giardia duodenalis from France. J Antimicrob Chemother 2000; 46:819-821.
5. Wensaas KA, Langeland N, Rortveit G. Prevalence of recurring symptoms after infection with Giardia lamblia in a nonendemic area. Scand J Prim Healthcare 2009; 27:12-17.
6. Muller J, SterkM, Hemphill A, et al. Characterization of Giardia lambliaWBC6 clones resistant to nitazoxanide and to metronidazole. J Antimicrob Chemother 2007; 60:280-287. (Pubitemid 47243875)
7. Morgan UM, Reynoldson JA, Thompson RC. Activities of several benzimidazoles and tubulin inhibitors against Giardia spp. in vitro. Antimicrob Agents Chemother 1993; 37:328-331. (Pubitemid 23046578)
8. Solaymani-Mohammadi S, Genkinger JM, Loffredo CA, et al. A meta-analysis of the effectiveness of albendazole compared with metronidazole as treatments for infections with Giardia duodenalis. PLoS Negl Trop Dis 2010; 4:e682.
9. Morch K, Hanevik K, Robertson LJ, et al. Treatment-ladder and genetic characterisation of parasites in refractory giardiasis after an outbreak in Norway. J Infect 2008; 56:268-273.
10. Alksne LE, Dunman PM. Target-based antimicrobial drug discovery. Methods Mol Biol 2008; 431:271-283. (Pubitemid 351366066)
11. Pucci MJ. Novel genetic techniques and approaches in the microbial genomics era: identification and/or validation of targets for the discovery of new antibacterial agents. Drugs R D 2007; 8:201-212. (Pubitemid 47026338)
12. Li JW, Vederas JC. Drug discovery and natural products: end of an era or an endless frontier? Science 2009; 325:161-165.
13. Upcroft JA, Upcroft P. Drug susceptibility testing of anaerobic protozoa. Antimicrob Agents Chemother 2001; 45:1810-1814. (Pubitemid 32466353)
14. Valdez CA, Tripp JC, Miyamoto Y, et al. Synthesis and electrochemistry of 2-ethenyl and 2-ethanyl derivatives of 5-nitroimidazole and antimicrobial activity against Giardia lamblia. J Med Chem 2009; 52:4038-4053.
15. Chen CZ, Kulakova L, Southall N, et al. High-throughput Giardia lamblia viability assay using bioluminescent ATP content measurements. Antimicrob Agents Chemother 2011; 55:667-675.
16. Hounkong K, Sawangjaroen N, Phongpaichit S. A colorimetric method for the evaluation of antigiardial drugs in vitro. Exp Parasitol 2011; 127:600-603.
17. Gut J, Ang KK, Legac J, et al. An image-based assay for high throughput screening of Giardia lamblia. J Microbiol Methods 2011; 84:398-405.
18. Upcroft JA, Dunn LA, Wright JM, et al. 5-Nitroimidazole drugs effective against metronidazole-resistant Trichomonas vaginalis and Giardia duodenalis. Antimicrob Agents Chemother 2006; 50:344-347. (Pubitemid 43042942)
19. Nillius D, Muller J, Muller N. Nitroreductase (GlNR1) increases susceptibility of Giardia lamblia and Escherichia coli to nitro drugs. J Antimicrob Chemother 2011; 66:1029-1035.
20. Leitsch D, Burgess AG, Dunn LA, et al. Pyruvate:ferredoxin oxidoreductase and thioredoxin reductase are involved in 5-nitroimidazole activation while flavin metabolism is linked to 5-nitroimidazole resistance in Giardia lamblia. J Antimicrob Chemother 2011; 66:1756-1765.
21. Pal D, Banerjee S, Cui J, et al. Giardia, Entamoeba, and Trichomonas enzymes activate metronidazole (nitroreductases) and inactivate metronidazole (nitroimidazole reductases). Antimicrob Agents Chemother 2009; 53:458-464.
22. Leitsch D, Kolarich D, Wilson IB, et al. Nitroimidazole action in Entamoeba histolytica: a central role for thioredoxin reductase. PLoS Biol 2007; 5:e211.
23. Dunn LA, Burgess AG, Krauer KG, et al. A new-generation 5-nitroimidazole can induce highly metronidazole-resistant Giardia lamblia in vitro. Int J Antimicrob Agents 2010; 36:37-42.
24. Navarrete-Vazquez G, Chavez-Silva F, Argotte-Ramos R, et al. Synthesis of benzologues of nitazoxanide and tizoxanide: a comparative study of their in vitro broad-spectrum antiprotozoal activity. Bioorg Med Chem Lett 2011; 21:3168-3171.
25. Torres-Gomez H, Hernandez-Nunez E, Leon-Rivera I, et al. Design, synthesis and in vitro antiprotozoal activity of benzimidazole-pentamidine hybrids. Bioorg Med Chem Lett 2008; 18:3147-3151. (Pubitemid 351721012)
26. Perez-Villanueva J, Santos R, Hernandez-Campos A, et al. Towards a systematic characterization of the antiprotozoal activity landscape of benzimidazole derivatives. Bioorg Med Chem 2010; 18:7380-7391.
27. Nava-Zuazo C, Estrada-Soto S, Guerrero-Alvarez J, et al. Design, synthesis, and in vitro antiprotozoal, antimycobacterial activities of N-{2-[(7-chloroquinolin-4-yl)amino]ethyl}ureas. Bioorg Med Chem 2010; 18:6398-6403.
28. Manna D, Dutta PK, Achari B, et al. A novel galacto-glycerolipid from Oxalis corniculata kills Entamoeba histolytica and Giardia lamblia. Antimicrob Agents Chemother 2010; 54:4825-4832.
29. Al-Jaber HI, Mosleh IM, Mallouh A, et al. Chemical constituents of Osyris alba and their antiparasitic activities. J Asian Nat Prod Res 2010; 12:814-820.
30. Sterk M, Muller J, Hemphill A, et al. Characterization of a Giardia lamblia WB C6 clone resistant to the isoflavone formononetin. Microbiology 2007; 153:4150-4158.
31. Lauwaet T, Andersen Y, Van de Ven L, et al. Rapid detachment of Giardia lamblia trophozoites as a mechanism of antimicrobial action of the isoflavone formononetin. J Antimicrob Chemother 2010; 65:531-534.
32. Knodler LA, Sekyere EO, Stewart TS, et al. Cloning and expression of a prokaryotic enzyme, arginine deiminase, from a primitive eukaryote Giardia intestinalis. J Biol Chem 1998; 273:4470-4477. (Pubitemid 28103186)
33. Touz MC, Ropolo AS, Rivero MR, et al. Arginine deiminase has multiple regulatory roles in the biology of Giardia lamblia. J Cell Sci 2008; 121:2930-2938.
34. Li Z, Kulakova L, Li L, et al. Mechanisms of catalysis and inhibition operative in the arginine deiminase from the human pathogen Giardia lamblia. Bioorg Chem 2009; 37:149-161.
35. Li Z, Liu Z, Cho DW, et al. Rational design, synthesis and evaluation of first generation inhibitors of the Giardia lamblia fructose-1,6-biphosphate aldolase. J Inorg Biochem 2011; 105:509-517.
36. Franzen O, Jerlstrom-Hultqvist J, Castro E, et al. Draft genome sequencing of Giardia intestinalis assemblage B isolate GS: is human giardiasis caused by two different species? PLoS Pathog 2009; 5:e1000560.
37. Paredez AR, Assaf ZJ, Sept D, et al. An actin cytoskeleton with evolutionarily conserved functions in the absence of canonical actin-binding proteins. Proc Natl Acad Sci USA 2011; 108:6151-6156.